EastWest Bioscience Inc.
HBOSF · OTC
7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | -32% | -34% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 4.5% | 11% | 25.5% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 |
| Operating Expenses | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 |
| % Margin | -354% | -196.2% | -234.1% |
| Other Income/Exp. Net | $0 | $0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 |
| Tax Expense | -$0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | -256.2% | -122.7% | -262.5% |
| EPS | -0.017 | -0.014 | -0.046 |
| % Growth | -25.7% | 70.8% | – |
| EPS Diluted | -0.017 | -0.014 | -0.046 |
| Weighted Avg Shares Out | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | -262.9% | -187.6% | -224.4% |